Skip to content
Menu

Head-to-head comparison

LillyDirect Foundayo vs RxSpan MD

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #38
LillyDirect Foundayo

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

Marked down on: Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI

vs
Ranked #5Desk pick
RxSpan MD

A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.

$249/mo sema · $329/mo tirz · Verified August 2026

Marked down on: You pay before a clinician reads your intake, and RxSpan MD publishes no refund policy — the word "refund" appears nowhere on the site, and the terms of service say only that you agree to pay all fees. The cheapest advertised rate is a single upfront payment of $2,094 for a year of semaglutide, and the plan card says it auto-renews

RxSpan MD takes this head-to-head with the higher Desk Score, 88/100 (B+) against 82/100 (B−) for LillyDirect Foundayo. LillyDirect Foundayo still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

LillyDirect Foundayo

82/100

B−

Overall

RxSpan MD

88/100

B+

Price transparency

86
84

State access

86
97

Molecule range

69
94

Onboarding speed

86
84

Support responsiveness

71
82

Licensing & trust

97
86

The spec sheet

FieldLillyDirect FoundayoRxSpan MD
SemaglutideNot listed on LillyDirect Foundayo's site (checked July 2026)$249/mo$249/mo month-to-month (compounded injection; $219/mo on a 3-month plan, $199/mo on 6 months, $175/mo on the 12-month plan billed as one payment of $2,094 up front with the sitewide STARTNOW code); oral capsules $249/mo on the same ladder, as low as $162/mo billed $1,933 up front
TirzepatideNot listed on LillyDirect Foundayo's site (checked July 2026)$329/mo$329/mo month-to-month (compounded injection; $243/mo on the 12-month plan billed as one payment of $2,905 up front with the STARTNOW code); oral capsules $349/mo
CoverageAll 50 statesAll 50 states (varies by provider licensure; no state list published)
Brand-nameYesYes
Oral optionYesYes
Best forPatients with commercial insurance who want the cheapest legal brand-name GLP-1.Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.
Desk Score82/100B−88/100B+

The verdict

Desk pick — RxSpan MD

RxSpan MD takes this head-to-head with the higher Desk Score, 88/100 (B+) against 82/100 (B−) for LillyDirect Foundayo. LillyDirect Foundayo still holds its ground where its strengths line up with yours.

Choose LillyDirect Foundayo if…

Patients with commercial insurance who want the cheapest legal brand-name GLP-1.

All 50 states

Choose RxSpan MD if…

Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.

$249/mo sema · $329/mo tirz · All 50 states (varies by provider licensure; no state list published)

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: LillyDirect Foundayo · RxSpan MD.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.